Affinage · Toxoplasma gondii

GAPDH2

glyceraldehyde-3-phosphate dehydrogenase GAPDH2 · UniProt A0A125YM60

Annotated
2026-09-08
2 papers in source corpus 2 papers cited in narrative 4 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

GAPDH2 is an apicoplast-localized enzyme of Toxoplasma gondii that supplies reducing power to organellar metabolism and is required for tachyzoite proliferation (PMID:36449552). Endogenous tagging places the protein within the apicoplast (PMID:36449552), and conditional depletion arrests parasite growth in the lytic cycle (PMID:36449552). Functionally, GAPDH2 provides NADPH to apicoplast pathways: its loss reduces isoprenoid precursor synthesis through the MEP pathway and diminishes de novo fatty acid synthesis in the organelle (PMID:36449552). Beyond this metabolic role, no further mechanistic detail has been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 4 steps
  1. 2022 High

    Establishing where GAPDH2 acts was the first step; endogenous tagging localized it to the apicoplast, distinguishing it from cytosolic glycolytic enzymes and framing a role in organellar metabolism.

    Evidence Endogenous tagging and fluorescence localization in T. gondii

    PMID:36449552

    Open questions at the time
    • Sub-organellar localization within the apicoplast not resolved
    • Import/targeting mechanism not defined
  2. 2022 High

    Whether GAPDH2 is dispensable was tested by conditional knockdown, which arrested tachyzoite growth and established the enzyme as essential to the lytic cycle.

    Evidence Conditional depletion with growth-arrest phenotype readout in T. gondii

    PMID:36449552

    Open questions at the time
    • Whether growth arrest reflects a single metabolic deficit or pleiotropic effects not dissected
    • Requirement in other life-cycle stages (bradyzoite, in vivo) not addressed
  3. 2022 High

    The metabolic consequence of depletion was measured to define GAPDH2's biochemical output, showing it supplies NADPH that feeds the MEP isoprenoid pathway and de novo fatty acid synthesis in the apicoplast.

    Evidence Conditional depletion combined with quantification of MEP pathway intermediates and fatty acid synthesis assays in T. gondii

    PMID:36449552

    Open questions at the time
    • Direct enzymatic characterization (NADPH-dependent kinetics) not reported
    • Contribution to the ferredoxin redox system not directly measured
    • Whether NADPH supply is the sole essential function unresolved
  4. 2023 Low

    Whether GAPDH2 activity is post-translationally regulated was probed by identifying it as a candidate interactor/substrate of the apicoplast deacetylase TgKDAC4, raising the possibility of acetylation-based control.

    Evidence Immunoprecipitation followed by mass spectrometry identifying TgGAPDH2 with acetylation sites in T. gondii

    PMID:37375060

    Open questions at the time
    • Single Co-IP/MS identification with no functional validation of the interaction or acetylation
    • Effect of acetylation on GAPDH2 enzymatic activity not tested
    • No reciprocal validation of the TgKDAC4 interaction

Open questions

Synthesis pass · forward-looking unresolved questions
  • How GAPDH2 is enzymatically regulated and whether its acetylation state modulates apicoplast NADPH supply remain open.
  • No functional link established between TgKDAC4-mediated deacetylation and GAPDH2 activity
  • No structural or kinetic model of the enzyme
  • Role across life-cycle stages and in vivo not characterized

Mechanism profile

Synthesis pass · controlled-vocabulary classification

Evidence

Reading pass · 4 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2022 GAPDH2 (phosphoglyceraldehyde dehydrogenase 2) localizes to the apicoplast of Toxoplasma gondii, as determined by endogenous tagging. Endogenous tagging / fluorescence localization PLoS pathogens High 36449552
2022 Conditional knockdown of GAPDH2 is critical for tachyzoite proliferation; its depletion inhibits parasite growth, demonstrating an essential role in the lytic cycle. Conditional depletion (knockdown) with growth arrest phenotype readout PLoS pathogens High 36449552
2022 GAPDH2 supplies NADPH (reducing power) to apicoplast metabolic pathways; its knockdown reduces isoprenoid precursor synthesis via the MEP pathway and reduces de novo fatty acid synthesis in the apicoplast. Conditional depletion combined with measurement of MEP pathway intermediates and fatty acid synthesis assays PLoS pathogens High 36449552
2023 TgGAPDH2 was identified as a potential interaction partner or substrate of the apicoplast deacetylase TgKDAC4 by immunoprecipitation followed by mass spectrometry; TgGAPDH2 contains acetylation sites. Immunoprecipitation followed by mass spectrometry (IP-MS) Microorganisms Low 37375060

Source papers

Stage 0 corpus · 2 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2022 Two apicoplast dwelling glycolytic enzymes provide key substrates for metabolic pathways in the apicoplast and are critical for Toxoplasma growth. PLoS pathogens 20 36449552
2023 TgKDAC4: A Unique Deacetylase of Toxoplasma's Apicoplast. Microorganisms 3 37375060